Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SIRT”

Showing 7 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05992584
What this trial is testing

Lenvatinib, Sintilimab Plus SIRT for Unresectable HCC

Who this might be right for
Hepatocellular Carcinoma
Second Affiliated Hospital of Guangzhou Medical University 30
Not applicableStudy completedNCT00951392
What this trial is testing

Implication of Metabolic and Genomic Modifications in Elderly Subjects

Who this might be right for
Insulin SensitivityAging
Hospices Civils de Lyon 35
Not applicableUnknownNCT06266247
What this trial is testing

How Sirtuin Levels Change During Behçet Disease

Who this might be right for
Behçet DiseaseInflammationVasculitis
Karamanoğlu Mehmetbey University 60
Testing effectiveness (Phase 2)Looking for participantsNCT06313203
What this trial is testing

HAI-Floxuridine, or SIRT, Combined With Gemox For Patients With Intra-Hepatic Cholangiocarcinoma Not Amenable to Resection (TOMCAT)

Who this might be right for
Intrahepatic CholangiocarcinomaChemotherapy Effect
Oslo University Hospital 39
Not applicableEnrolling By InvitationNCT06712017
What this trial is testing

Observational Study for SIR-Spheres Therapy for the Treatment of HCC Patients in China

Who this might be right for
Hepatocellular Carcinoma (HCC)Hepatocellular Carcinoma Non-Resectable
GrandPharma (China) Co., Ltd. 100
Not applicableStudy completedNCT03109262
What this trial is testing

Yttrium-90 (Y90) Glass Microspheres PET/CT in Imaging Patients With Liver Tumors

Who this might be right for
Primary Malignant Liver Neoplasm
Stanford University 42
Testing effectiveness (Phase 2)Looking for participantsNCT06773845
What this trial is testing

Building Evidence for Ablative Internal Radiation Therapy in Localized HCC Beyond the Up-To-7 Criteria

Who this might be right for
Hepatocellular Carcinoma (HCC)Radioembolization
Seoul National University Hospital 100

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation